期刊文献+

BRAF和EphB2在人结直肠锯齿状腺瘤中的表达及意义 被引量:3

Expression and significance of BRAF and EphB2 in human colorectal serrated adenomas
下载PDF
导出
摘要 目的:探讨鼠类肉瘤滤过性病毒致癌基因同源体B1(v-raf murine sarcoma viral oncogene homolog B1,BRAF)和生促红素人肝细胞蛋白(erythropoietin-producing hepatoma cell line B2,EphB2)在人结直肠锯齿状腺瘤中的表达及其意义。方法:收集滨州医学院附属医院1996年1月至2008年5月10例正常结直肠肠黏膜、21例增生性息肉、22例锯齿状腺瘤、55例腺瘤性息肉(18例管状腺瘤、16例管状绒毛状腺瘤、21例绒毛状腺瘤)石蜡标本。免疫组织化学法检测BRAF和EphB2蛋白的表达量,同时观察蛋白的表达部位。结果:增生性息肉中BRAF蛋白阳性细胞多位于隐窝中下区域,腺瘤性息肉的阳性细胞多表达位于隐窝上部区域,而锯齿状腺瘤阳性细胞多表达于隐窝全层。锯齿状腺瘤与腺瘤性息肉的BRAF蛋白表达量相近[(0.129±0.030)vs(0.130±0.026),P>0.05],但远高于增生性息肉[(0.129±0.030)vs(0.102±0.014),P<0.01];锯齿状腺瘤、管状腺瘤、管状绒毛状腺瘤、绒毛状腺瘤之间BRAF蛋白表达量差异无统计学意义[(0.129±0.030)vs(0.116±0.019),(0.119±0.037),(0.122±0.008),P>0.05]。增生性息肉中EphB2蛋白阳性细胞多位于隐窝中下区域细胞膜上,腺瘤性息肉EphB2蛋白阳性细胞位于隐窝上部,而锯齿状腺瘤EphB2蛋白阳性细胞表达于隐窝全层。锯齿状腺瘤与腺瘤性息肉的EphB2蛋白表达量相近[(0.138±0.024)vs(0.139±0.025),P>0.05],而远高于增生性息肉[(0.138±0.024)vs(0.169±0.018),P<0.01];锯齿状腺瘤与管状腺瘤、管状绒毛状腺瘤、绒毛状腺瘤间EphB2蛋白表达量无区别[(0.138±0.024)vs(0.143±0.027),(0.139±0.028),(0.133±0.021),P>0.05]。结论:BRAF和EphB2蛋白在增生性息肉、腺瘤性息肉中隐窝部分区域表达,而在锯齿状腺瘤中隐窝全层表达,提示锯齿状腺瘤是一类独立的不同于腺瘤性息肉的结直肠肿瘤。 Objective:To discuss the expression and significance of v-raf murine sarcoma viral oncogene homolog B1(BRAF) and erythropoietin-producing hepatoma cell line B2(EphB2) in human colorectal serrated adenomas.Methods: Collect 10 paraffin specimens of normal mucosa,21 cases of hyperplastic polyp,22 cases of serrated adenomas and 55 cases of traditional colorectal adenomas(18 tubular adenomas,16 tubulovillous adenomas,21 villous adenomas) in the Affiliated Hospital of Binzhou Medical College between Jan.1996 to May.2008.The expression levels and sites of BRAF and EphB2 protein were examined by immunohistochemical method.Results: Most BRAF protein positive cells in hyperplastic polyp were located in the lower crypt,those in adenomatous polyp located in upper crypt,and those in serrated adenomas almost expressed in the whole crypt.The expression of BRAF protein was similar in serrated adenomas and adenomatous polyp(0.129±0.030 vs 0.130±0.026,P0.05),while more higher than that in hyperplastic polyp(0.129±0.030 vs 0.102±0.014,P0.01).There was no significant difference in BRAF protein expression among the serrated adenomas,tubular adenomas,tubulovillous adenomas and villous adenomas(0.129±0.030 vs 0.116±0.019,0.119±0.037,0.122±0.008,P0.05).The EphB2 protein positive cells in hyperplastic polyp was almost located in the membrane of the middle and lower region of crypt,those in adenomatous polyp located in the upper crypt,and those in serrated adenomas expressed in the whole crypt.The EphB2 protein expression in serrated adenomas and adenomatous polyp was similar(0.138±0.024 vs 0.139±0.025,P0.05),but much higher than that in hyperplastic polyp(0.138±0.024 vs 0.169±0.018,P0.01).No significant difference was found in EphB2 among serrated adenomas,tubular adenomas,tubulovillous adenomas and villous adenomas(0.138±0.024 vs 0.143±0.027,0.139±0.028,0.133±0.021,P0.05).Conclusion: BRAF and EphB2 proteins both in hyperplastic polyp and adenomatous polyp are expressed partly in crypt,while those in colorectal serrated adenomas are expressed in the whole crypt,indicating that serrated adenomas may be an independent tumor difference from adenomatous polyp.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2012年第2期186-190,共5页 Chinese Journal of Cancer Biotherapy
基金 山东省教育厅科技计划项目资助(No.J06L52)~~
关键词 锯齿状腺瘤 BRAF EPHB2 增生性息肉 腺瘤性息肉 结直肠肿瘤 serrated adenoma BRAF EphB2 hyperplastic polyp adenomatous polyp colorectal tumor
  • 相关文献

参考文献20

  • 1Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer [J]. Nature, 2002, 417 (6892): 949-954.
  • 2O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points [J]. Am J Surg Pathol, 2006, 30 (12) : 1491-1501.
  • 3Velho S, Moutinho C, Cimes L, et al. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis [ J ]. BMC Cancer, 2008, 8: 255.
  • 4Kiyokawa E, Takai S, Tanaka M, et al. Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors [J]. Cancer Res, 1994, 54(14): 3645-3650.
  • 5Wu Q, Suo Z, Risberg B, et al. Expression of Ephb2 and Ephb4 in breast carcinoma [J]. Pathol Oncol Res, 2004, 10( 1 ) : 26-33.
  • 6Allazzouzi kl, Davalos V, Kokko A, et al. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in eolorectal tumors [J]. CancerRes, 2005, 65(22): 10170-10173.
  • 7Nakada M, Niska JA, Miyamori H, et al. The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma ceils [J]. Cancer Res, 2004, 64(9) : 3179-3185.
  • 8Jubb AM, Zhong F, Bheddah S, et al. EphB2 is a prognostic factors in colorectal cancer [ J ]. Clin Cancer Res, 2005, 11 ( 14 ) : 5181-5187.
  • 9Huusko P, Ponciano-Jackson D, Wolf M, et al. Nonsense-mediated decay microarray analysis identifies mutations of EphB2 in human prostate cancer [J]. Nat Genet, 2004, 36(9) : 979-983.
  • 10Sawamiphak S, Seidel S, Essmann CL, et al. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis [ J ]. Nature, 2010, 465(7297): 487-491.

同被引文献54

  • 1Torlakovic E, Skovlund E, Snorer DC, et al. Morphologic reappraisal of serrated colorectal polyps [J]. Am J Surg Pathol, 2003,27( 1 ) :65-81.
  • 2Shover DC, Jass JR, Fenoglio-Preiser C, et al. Serrated polyps of the large intestine:a morphologic and molecular review of an evolving concept [ J ]. Am J Clin Patho1,2005,124 ( 3 ) : 380 -391.
  • 3Chlumsk6 A, Boudov6 L,ZOmecnfk M. Sessile serrated adenomas of the large bowel. Clinicopathologic and including comparison with common hyperplastic polyps adenomas [J]. Cesk Patol,2006,42(3) : 133-138.
  • 4study and Kambara T, Simms LA, Whitehall VL, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum [ J ]. Gut ,2004,53 ( 8 ) : 1137-1144.
  • 5O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability,CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points [ J ]. Am J Surg Patho1,2006,30 ( 12 ) : 1491-1501.
  • 6Velho S,Moutinho C,Cirnes L,et al. BRAF,KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in eolorectal carcinogenesis [J]. BMC Cancer,2008,8:255.
  • 7Sawamiphak S, Seidel S, Essmann CL, et al. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis [ J]. Nature ,2010,465 (7297) :487-491.
  • 8Genander M, Frisn J. Ephrins and Eph receptors in stem cells and cancer [ J]. Curr Opin Cell Bio1,2010,22 ( 5 ) :611-616.
  • 9Deqin M, Chen Z, Nero C, et al. Somatic deletions of the polyA tract in the 3 ' untranslated region of epidermal growth factor receptor are common in microsatellite instability-high endometrial and colorectal carcinomas [ J]. Arch Pathol Lab Med,2012,136(5 ) :510-516.
  • 10O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct coloreetal carcinoma end points [ J]. Am J Surg Patho1,2006,30 ( 12 ) :1491-1501.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部